U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review-Reference-Cited by-同舟云学术

U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review

Published:2021-10-28 Issue: Volume: Page:
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Arora Shaily,Narayan Preeti,Osgood Christy L.,Wedam Suparna^ORCID,Prowell Tatiana M.^ORCID,Gao Jennifer J.^ORCID,Shah Mirat,Krol Danielle,Wahby Sakar,Royce Melanie^ORCID,Ghosh Soma,Philip Reena,Ison Gwynn,Berman Tara,Brus Christina,Bloomquist Erik W.,Fiero Mallorie H.,Tang Shenghui,Pazdur Richard,Ibrahim Amna^ORCID,Amiri-Kordestani Laleh,Beaver Julia A.

Funder

HHS | U.S. Food and Drug Administration

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

2. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells;Cancer Letters;2024-08

3. Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer;Breast Cancer: Targets and Therapy;2024-08

4. Creatine Kinase (CK)-MB and CK-MB-to-Total-CK Ratio: A Novel Predictive Marker for Pathologic Complete Response in Breast Cancer Treated with Neoadjuvant Chemotherapy;International Journal of Hematology and Oncology;2024-06-30

5. Improving Dissolution Rate and Solubility of Palbociclib Salts/Cocrystal for Anticancer Efficacy;Journal of Molecular Structure;2024-06